Veterinary medicinal product register

The FVS registers website is using cookies. By continuing using this website you are agreeing to use cookies. Agree Cookies policy
Data selected by 2
Original name Strength Marketing authorisation number Marketing authorisation holder: ATCvet code Species More
Biofel PCH - V/NRP/17/0005 Bioveta, a.s., Čehija QI06AA04 cats Vairāk

Medicinal product information

Pharmaceutical form: emulsion for injection
International name (active substance): Inactivated feline panleucopenia virus, strain FPV Bio 7,Inactivated feline calicivirus, strain FCV F9 Bio-8,Inactivated feline herpes virus, strain FHV 1 Bio-9
Distribution category: To be used only by veterinary surgeon
Manufacturer(s) responsible for batch release Bioveta, a.s., Čehija
Date of authorisation/renewal: 20-Dec-2021
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [DOCX] 211221LI (21-Dec-2021)
Labelling text: [DOCX] 211221M (21-Dec-2021)
Summary of product characteristics: [DOC] 211221ZA (21-Dec-2021)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/17/0005-01 2 Stikla flakons, 1 deva -
V/NRP/17/0005-02 10 Stikla flakons, 1 deva -
V/NRP/17/0005-03 5 Stikla flakons, 5 deva -
V/NRP/17/0005-04 10 Stikla flakons, 5 deva -
V/NRP/17/0005-05 20 Stikla flakons, 1 deva -
V/NRP/17/0005-06 100 Stikla flakons, 1 deva -
V/NRP/17/0005-07 1 Stikla flakons, 5 deva -
BIO KILL 2,5 mg/1 ml spray 2.5 mg/ml V/NRP/99/0989 Bioveta, a.s., Čehija QP53AC04 domestic animals Vairāk

Medicinal product information

Pharmaceutical form: cutaneous spray, solution
International name (active substance): Permethrin
Distribution category: Nonprescription veterinary medicinal product
Manufacturer(s) responsible for batch release Bioveta, a.s., Čehija
Date of authorisation/renewal: 30-Apr-2009
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] 300913LI (03-Oct-2013)
Labelling text: [PDF] 300913M (03-Oct-2013)
Summary of product characteristics: [PDF] 300913ZA (03-Oct-2013)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/99/0989-01 2,5 mg/ml 1 Polietilēna flakons, 100 ml -
V/NRP/99/0989-09 2,5 mg/ml 1 Flakons, 500 ml -
Phenosan 12.5 mg V/DCP/25/0009 Alfasan Nederland BV, Nīderlande QN03AA02 dogs Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Phenobarbital
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Alfasan Nederland BV, Nīderlande;Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 19-Mar-2025
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (19-Mar-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (19-Mar-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (19-Mar-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/25/0009-01 1 Blisteris, 10 tablete -
V/DCP/25/0009-02 2 Blisteris, 10 tablete -
V/DCP/25/0009-03 3 Blisteris, 10 tablete -
V/DCP/25/0009-04 4 Blisteris, 10 tablete -
V/DCP/25/0009-05 5 Blisteris, 10 tablete -
V/DCP/25/0009-06 6 Blisteris, 10 tablete -
V/DCP/25/0009-07 7 Blisteris, 10 tablete -
V/DCP/25/0009-08 8 Blisteris, 10 tablete -
V/DCP/25/0009-09 9 Blisteris, 10 tablete -
V/DCP/25/0009-10 10 Blisteris, 10 tablete -
V/DCP/25/0009-11 25 Blisteris, 10 tablete -
Phenosan 50 mg V/DCP/25/0010 Alfasan Nederland BV, Nīderlande QN03AA02 dogs Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Phenobarbital
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Alfasan Nederland BV, Nīderlande;Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 19-Mar-2025
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (19-Mar-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (19-Mar-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (19-Mar-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/25/0010-01 1 Blisteris, 10 tablete -
V/DCP/25/0010-02 2 Blisteris, 10 tablete -
V/DCP/25/0010-03 3 Blisteris, 10 tablete -
V/DCP/25/0010-04 4 Blisteris, 10 tablete -
V/DCP/25/0010-05 5 Blisteris, 10 tablete -
V/DCP/25/0010-06 6 Blisteris, 10 tablete -
V/DCP/25/0010-07 7 Blisteris, 10 tablete -
V/DCP/25/0010-08 8 Blisteris, 10 tablete -
V/DCP/25/0010-09 9 Blisteris, 10 tablete -
V/DCP/25/0010-10 10 Blisteris, 10 tablete -
V/DCP/25/0010-11 25 Blisteris, 10 tablete -
Vetmedin S 1.25 mg V/MRP/15/0011 Boehringer Ingelheim Vetmedica GmbH, Vācija QC01CE90 dogs Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Pimobendan
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lavet Pharmaceuticals, Ungārija
Date of authorisation/renewal: 02-Jan-2020
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (19-Apr-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (19-Apr-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (19-Apr-2024)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/15/0011-01 1,25 mg 2 PVH/Al blisteris, 10 tablete -
V/MRP/15/0011-02 1,25 mg 5 PVH/Al blisteris, 10 tablete -
V/MRP/15/0011-03 1,25 mg 10 PVH/Al blisteris, 10 tablete -
Cladaxxa 40 mg/10 mg - V/MRP/22/0006 KRKA d.d. Novo Mesto, Slovēnija QJ01CR02 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Amoxicillin trihydrate, Potassium clavulanate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release KRKA d.d. Novo Mesto, Slovēnija
Date of authorisation/renewal: 23-Feb-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [DOCX] 15122023LI (15-Dec-2023)
Labelling text: [DOCX] 15122023M (15-Dec-2023)
Summary of product characteristics: [DOCX] 15122023ZA (15-Dec-2023)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/22/0006-01 1 OPA/Al/PE/desikants/Al/PE blisteris, 10 tablete -
V/MRP/22/0006-02 2 OPA/Al/PE/desikants/Al/PE blisteris, 10 tablete -
V/MRP/22/0006-03 10 OPA/Al/PE/desikants/Al/PE blisteris, 10 tablete -
V/MRP/22/0006-04 50 OPA/Al/PE/desikants/Al/PE blisteris, 10 tablete -
Cladaxxa 200 mg/50 mg - V/MRP/22/0007 KRKA d.d. Novo Mesto, Slovēnija QJ01CR02 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Amoxicillin trihydrate, Potassium clavulanate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release KRKA d.d. Novo Mesto, Slovēnija
Date of authorisation/renewal: 23-Feb-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [DOCX] 15122023LI (15-Dec-2023)
Labelling text: [DOCX] 15122023M (15-Dec-2023)
Summary of product characteristics: [DOCX] 15122023ZA (15-Dec-2023)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/22/0007-01 1 OPA/Al/PE/desikants/Al/PE blisteris, 10 tablete -
V/MRP/22/0007-02 2 OPA/Al/PE/desikants/Al/PE blisteris, 10 tablete -
V/MRP/22/0007-03 10 OPA/Al/PE/desikants/Al/PE blisteris, 10 tablete -
V/MRP/22/0007-04 50 OPA/Al/PE/desikants/Al/PE blisteris, 10 tablete -
Cladaxxa 400 mg/100 mg - V/MRP/22/0008 KRKA d.d. Novo Mesto, Slovēnija QJ01CR02 dogs Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Amoxicillin trihydrate, Potassium clavulanate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release KRKA d.d. Novo Mesto, Slovēnija
Date of authorisation/renewal: 23-Feb-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [DOCX] 15122023LI (15-Dec-2023)
Labelling text: [DOCX] 15122023M (15-Dec-2023)
Summary of product characteristics: [DOCX] 15122023ZA (15-Dec-2023)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/22/0008-01 2 OPA/Al/PE/desikants/Al/PE blisteris, 6 tablete -
V/MRP/22/0008-02 10 OPA/Al/PE/desikants/Al/PE blisteris, 6 tablete -
V/MRP/22/0008-03 50 OPA/Al/PE/desikants/Al/PE blisteris, 6 tablete -
Furosoral vet 40 mg V/MRP/14/0063 Le Vet Beheer B.V., Nīderlande QC03CA01 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Furosemide
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lelypharma B.V., Nīderlande;Artesan Pharma, Vācija;GENERA Inc., Horvātija
Date of authorisation/renewal: 01-Aug-2019
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [DOCX] 20032024LI (20-Mar-2024)
Labelling text: [DOCX] 20032024M (20-Mar-2024)
Summary of product characteristics: [DOCX] 20032024ZA (20-Mar-2024)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/14/0063-01 40 mg 1 PVH/PVDH alumīnija blisteris (caurspīdīgs), 10 tablete -
V/MRP/14/0063-02 40 mg 2 PVH/PVDH alumīnija blisteris (caurspīdīgs), 10 tablete -
V/MRP/14/0063-03 40 mg 3 PVH/PVDH alumīnija blisteris (caurspīdīgs), 10 tablete -
V/MRP/14/0063-04 40 mg 4 PVH/PVDH alumīnija blisteris (caurspīdīgs), 10 tablete -
V/MRP/14/0063-05 40 mg 5 PVH/PVDH alumīnija blisteris (caurspīdīgs), 10 tablete -
V/MRP/14/0063-06 40 mg 6 PVH/PVDH alumīnija blisteris (caurspīdīgs), 10 tablete -
V/MRP/14/0063-07 40 mg 7 PVH/PVDH alumīnija blisteris (caurspīdīgs), 10 tablete -
V/MRP/14/0063-08 40 mg 8 PVH/PVDH alumīnija blisteris (caurspīdīgs), 10 tablete -
V/MRP/14/0063-09 40 mg 9 PVH/PVDH alumīnija blisteris (caurspīdīgs), 10 tablete -
V/MRP/14/0063-10 40 mg 10 PVH/PVDH alumīnija blisteris (caurspīdīgs), 10 tablete -
V/MRP/14/0063-11 40 mg 25 PVH/PVDH alumīnija blisteris (caurspīdīgs), 10 tablete -
V/MRP/14/0063-12 40 mg 50 PVH/PVDH alumīnija blisteris (caurspīdīgs), 10 tablete -
V/MRP/14/0063-13 40 mg 100 PVH/PVDH alumīnija blisteris (caurspīdīgs), 10 tablete -
V/MRP/14/0063-14 40 mg 1 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/MRP/14/0063-15 40 mg 2 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/MRP/14/0063-16 40 mg 3 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/MRP/14/0063-17 40 mg 4 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/MRP/14/0063-18 40 mg 5 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/MRP/14/0063-19 40 mg 6 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/MRP/14/0063-20 40 mg 7 PVDH/PE/PVH/Al blisteris, 10 tablete -
BioBos Respi 3 - V/MRP/18/0040 Bioveta, a.s., Čehija QI02AL04 cattle Vairāk

Medicinal product information

Pharmaceutical form: suspension for injection
International name (active substance): Inactivated bovine respiratory syncytial virus, strain BIO-24,Inactivated bovine parainfluenza-3 virus, strain BIO-23,Mannheimia (Pasteurella) haemolytica inactivated, strain DSM 5283, serotype A1
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Bioveta, a.s., Čehija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (21-Jul-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (21-Jul-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (21-Jul-2025)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/18/0040-01 1 Plastmasas flakons, 5 deva -
V/MRP/18/0040-02 1 Plastmasas flakons, 25 deva -
V/MRP/18/0040-03 1 Plastmasas flakons, 50 deva -
V/MRP/18/0040-04 1 Stikla flakons, 5 deva -
V/MRP/18/0040-05 1 Stikla flakons, 25 deva -
V/MRP/18/0040-06 1 Stikla flakons, 50 deva -
V/MRP/18/0040-07 10 Plastmasas flakons, 5 deva -
V/MRP/18/0040-08 10 Stikla flakons, 5 deva -
V/MRP/18/0040-09 10 Plastmasas flakons, 5 deva -
V/MRP/18/0040-10 10 Stikla flakons, 5 deva -
BioBos Respi 4 - V/MRP/18/0041 Bioveta, a.s., Čehija QI02AL cattle Vairāk

Medicinal product information

Pharmaceutical form: suspension for injection
International name (active substance): Inactivated bovine respiratory syncytial virus, strain BIO-24,Inactivated bovine parainfluenza-3 virus, strain BIO-23,Mannheimia (Pasteurella) haemolytica inactivated, strain DSM 5283, serotype A1,Inactivated bovine viral diarrhea virus, strain BIO-25
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Bioveta, a.s., Čehija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (21-Jul-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (21-Jul-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (21-Jul-2025)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/18/0041-01 1 Plastmasas flakons, 5 deva -
V/MRP/18/0041-02 1 Plastmasas flakons, 25 deva -
V/MRP/18/0041-03 1 Plastmasas flakons, 50 deva -
V/MRP/18/0041-04 1 Stikla flakons, 5 deva -
V/MRP/18/0041-05 1 Stikla flakons, 25 deva -
V/MRP/18/0041-06 1 Stikla flakons, 50 deva -
V/MRP/18/0041-07 10 Plastmasas flakons, 5 deva -
V/MRP/18/0041-08 10 Stikla flakons, 5 deva -
V/MRP/18/0041-09 10 Stikla flakons, 5 deva -
V/MRP/18/0041-10 10 Plastmasas flakons, 5 deva -
HuveGuard MMAT - V/MRP/16/0025 Huvepharma NV, Beļģija QI01AN01 chickens Vairāk

Medicinal product information

Pharmaceutical form: suspension for oral suspension
International name (active substance): Eimeria acervulina (strain RA|3+20), Eimeria maxima (strain MCK+10), Eimeria mitis (strain Jormit 3+9), Eimeria tenella (strain Rt 3+15)
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Bioveta, Bulgārija
Date of authorisation/renewal: 21-Sep-2020
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (07-May-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (07-May-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (28-Aug-2024)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/16/0025-01 1 ZBPE flakons, 1000 deva -
V/MRP/16/0025-02 5 ZBPE flakons, 1000 deva -
V/MRP/16/0025-03 10 ZBPE flakons, 1000 deva -
V/MRP/16/0025-04 1 ZBPE flakons, 5000 deva -
V/MRP/16/0025-05 5 ZBPE flakons, 5000 deva -
V/MRP/16/0025-06 10 ZBPE flakons, 5000 deva -
Quiflox 5 mg V/DCP/12/0073 KRKA, d.d., Novo mesto, Slovēnija QJ01MA93 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Marbofloxacin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release KRKA, d.d., Novo mesto, Slovēnija;TAD Pharma GmbH, Vācija
Date of authorisation/renewal: 03-Jan-2018
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (11-Sep-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (11-Sep-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (11-Sep-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/12/0073-01 5 mg 1 OPA/Al/PVH-Al blisteris, 10 tablete -
V/DCP/12/0073-02 5 mg 10 OPA/Al/PVH-Al blisteris, 10 tablete -
Quiflox 20 mg V/DCP/12/0074 KRKA, d.d., Novo mesto, Slovēnija QJ01MA93 dogs Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Marbofloxacin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release KRKA, d.d., Novo mesto, Slovēnija;TAD Pharma GmbH, Vācija
Date of authorisation/renewal: 03-Jan-2018
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (11-Sep-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (11-Sep-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (11-Sep-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/12/0074-01 20 mg 1 OPA/Al/PVH-Al blisteris, 10 tablete -
V/DCP/12/0074-02 20 mg 10 OPA/Al/PVH-Al blisteris, 10 tablete -
Dinolytic 5 mg/ml V/NRP/93/0031 Zoetis Belgium S.A., Beļģija QG02AD01 cattle; pigs; horses Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Dinoproston tromethamine
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Zoetis Belgium S.A., Beļģija;Zoetis Manufacturing & Research Spain, S.L. , Spānija
Date of authorisation/renewal: 22-Sep-2008
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_aprakst (02-Jun-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (02-Jun-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (02-Jun-2025)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/93/0031-02 5 mg/ml 5 stikla flakons bez pretplūsmas (ar sarkanu aizbāzni), 10 ml -
V/NRP/93/0031-03 5 mg/ml 1 stikla flakons bez pretplūsmas (ar sarkanu aizbāzni), 30 ml -
V/NRP/93/0031-04 5 mg/ml 1 stikla flakons bez pretplūsmas (ar sarkanu aizbāzni), 100 ml -
V/NRP/93/0031-05 5 mg/ml 5 stikla flakons ar pretplūsmu (ar sarkanu aizbāzni), 10 ml -
V/NRP/93/0031-06 5 mg/ml 5 stikla flakons bez pretplūsmas (ar pelēku aizbāzni), 10 ml -
V/NRP/93/0031-07 5 mg/ml 1 stikla flakons bez pretplūsmas (ar pelēku aizbāzni), 30 ml -
V/NRP/93/0031-08 5 mg/ml 1 stikla flakons bez pretplūsmas (ar pelēku aizbāzni), 100 ml -
V/NRP/93/0031-09 5 mg/ml 5 stikla flakons ar pretplūsmu (ar pelēku aizbāzni), 10 ml -
Valbendis 100 mg/ml V/DCP/25/0019 Industrial Veterinaria, S.A., Spānija QP52AC11 cattle; sheep Vairāk

Medicinal product information

Pharmaceutical form: suspension for oral use
International name (active substance): Albendazole
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release aniMedica GmbH, Vācija;Industrial Veterinaria, S.A., Spānija;aniMedica Herstellungs GmbH, Vācija
Date of authorisation/renewal: 24-Mar-2025
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (24-Mar-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (24-Mar-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (24-Mar-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/25/0019-01 1 ABPE pudele, 1 l -
V/DCP/25/0019-02 1 ABPE pudele, 5 l -
MYXOREN - V/NRP/02/1433 Bioveta, a.s., Čehija QI08AD02 rabbits Vairāk

Medicinal product information

Pharmaceutical form: lyophilisate and solvent for solution for injection
International name (active substance): Myxoma virus, strain CAMP V-219, Live
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Bioveta, a.s., Čehija
Date of authorisation/renewal: 18-May-2012
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (13-May-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (13-May-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (13-May-2025)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/02/1433-01 1 Flakons, 10 deva -
V/NRP/02/1433-02 5 Flakons, 10 deva -
V/NRP/02/1433-03 1 Flakons, 20 deva -
V/NRP/02/1433-04 5 Flakons, 20 deva -
V/NRP/02/1433-05 1 Flakons, 40 deva -
V/NRP/02/1433-06 5 Flakons, 40 deva -
V/NRP/02/1433-07 1 Flakons, 50 deva -
V/NRP/02/1433-08 5 Flakons, 50 deva -
V/NRP/02/1433-09 1 Flakons, 80 deva -
V/NRP/02/1433-10 5 Flakons, 80 deva -
V/NRP/02/1433-11 1 Flakons, 100 deva -
V/NRP/02/1433-12 5 Flakons, 100 deva -
V/NRP/02/1433-13 1 Flakons, 50 deva -
V/NRP/02/1433-14 5 Flakons, 50 deva -
V/NRP/02/1433-15 1 Flakons, 100 deva -
V/NRP/02/1433-16 5 Flakons, 100 deva -
V/NRP/02/1433-17 1 Flakons, 1 deva -
V/NRP/02/1433-18 5 Flakons, 1 deva -
V/NRP/02/1433-19 10 Flakons, 1 deva -
Advantage 80 mg V/NRP/25/0030 Elanco Animal Health GmbH, Vācija QP53AX17 large cats Vairāk

Medicinal product information

Pharmaceutical form: spot-on solution
International name (active substance): Imidacloprid
Distribution category: Nonprescription veterinary medicinal product
Manufacturer(s) responsible for batch release Bayer HealthCare AG, Vācija
Date of authorisation/renewal: 26-Feb-2013
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (06-Jun-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (06-Jun-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (06-Jun-2025)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/25/0030-01 80 mg 2 Polipropilēna pipete, 0,8 ml -
V/NRP/25/0030-02 80 mg 3 Polipropilēna pipete, 0,8 ml -
V/NRP/25/0030-03 80 mg 4 Polipropilēna pipete, 0,8 ml -
V/NRP/25/0030-04 80 mg 6 Polipropilēna pipete, 0,8 ml -
Suramox 500 mg/g V/NRP/08/1717 Virbac S.A., Francija QJ01CA04 chickens Vairāk

Medicinal product information

Pharmaceutical form: powder for oral solution
International name (active substance): Amoxicillin trihydrate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release FC France SAS, Francija
Date of authorisation/renewal: 16-Oct-2012
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (02-Apr-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (02-Apr-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (02-Apr-2025)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/08/1717-01 500 mg/g 1 Burciņa, 50 g -
V/NRP/08/1717-02 500 mg/g 1 Burciņa, 100 g -
V/NRP/08/1717-03 500 mg/g 1 Burciņa, 200 g -
V/NRP/08/1717-04 500 mg/g 1 Burciņa, 500 g -
V/NRP/08/1717-05 500 mg/g 1 Burciņa, 1000 g -
V/NRP/08/1717-06 500 mg/g 1 muciņa, 1500 g -
V/NRP/08/1717-07 500 mg/g 1 muciņa, 3000 g -
V/NRP/08/1717-08 500 mg/g 1 Maisiņš, 500 g -
V/NRP/08/1717-09 500 mg/g 1 Maisiņš, 1000 g -
V/NRP/08/1717-10 500 mg/g 1 Maisiņš, 2000 g -
V/NRP/08/1717-11 500 mg/g 1 Maisiņš, 3000 g -
Suramox 500 mg/g V/NRP/08/1716 Virbac S.A., Francija QJ01CA04 pigs Vairāk

Medicinal product information

Pharmaceutical form: powder for oral solution
International name (active substance): Amoxicillin trihydrate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release FC France SAS, Francija
Date of authorisation/renewal: 16-Oct-2012
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (02-Apr-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (02-Apr-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (02-Apr-2025)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/08/1716-01 500 mg/g 1 Burciņa, 50 g -
V/NRP/08/1716-02 500 mg/g 1 Burciņa, 100 g -
V/NRP/08/1716-03 500 mg/g 1 Burciņa, 200 g -
V/NRP/08/1716-04 500 mg/g 1 Burciņa, 500 g -
V/NRP/08/1716-05 500 mg/g 1 Burciņa, 1000 g -
V/NRP/08/1716-06 500 mg/g 1 muciņa, 1500 g -
V/NRP/08/1716-07 500 mg/g 1 muciņa, 3000 g -
V/NRP/08/1716-08 500 mg/ml 1 Maisiņš, 500 g -
V/NRP/08/1716-09 500 mg/g 1 Maisiņš, 1000 g -
V/NRP/08/1716-10 500 mg/g 1 Maisiņš, 2000 g -
V/NRP/08/1716-11 500 mg/g 1 Maisiņš, 3000 g -

3081 record

© Food and veterinary service · 2026 Cookies policy